Tears of detached retinal pigment epithelium.

Pathogenesis of tears of the retinal pigment epithelium. Br J Ophthalmol (1984) 1.79

Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol (1985) 1.74

Clinicopathological correlation of retinal pigment epithelial tears in exudative age related macular degeneration: pretear, tear, and scarred tear. Br J Ophthalmol (2001) 1.08

One-year results of combined photodynamic therapy and intravitreal bevacizumab injection for retinal pigment epithelial detachment secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2009) 1.07

Long-term visual outcome of pigment epithelial tears in association with anti-VEGF therapy of pigment epithelial detachment in AMD. Eye (Lond) (2011) 1.06

'Blow-outs' in the retinal pigment epithelium. Br J Ophthalmol (1987) 1.05

[Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress]. Ophthalmologe (2008) 1.02

Dehiscences of the pigment epithelium. Trans Am Ophthalmol Soc (1985) 1.00

Retinal pigment epithelial detachments in the elderly: a controlled trial of argon laser photocoagulation. Br J Ophthalmol (1982) 0.92

Bilaterality of tears of the retinal pigment epithelium. Br J Ophthalmol (1988) 0.91

Incidence of Retinal Pigment Epithelial Tears and Associated Risk Factors After Treatment of Age-Related Macular Degeneration with Intravitreal Anti-VEGF Injections. Open Ophthalmol J (2014) 0.88

Controlled trial of laser photocoagulation of pigment epithelial detachments in the elderly: 4 year review. Br J Ophthalmol (1992) 0.87

[Serous vascularized pigment epithelial detachment in exudative AMD. Morphological typing and risk of tears in the RPE]. Ophthalmologe (2015) 0.84

Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2014) 0.84

Retinal pigment epithelium tear after intravitreal aflibercept injection. Clin Ophthalmol (2013) 0.84

Retinal pigment epithelial tear following intravitreal ranibizumab injections for neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2007) 0.83

25th RCOphth Congress, President's Session paper: 25 years of progress in medical retina. Eye (Lond) (2014) 0.80

Fundus autofluorescence and spectral-domain optical coherence tomography findings suggesting tissue remodelling in retinal pigment epithelium tear. Br J Ophthalmol (2012) 0.80

Bilateral tears of the retinal pigment epithelium. Br J Ophthalmol (1988) 0.79

Detection of subpigment epithelial neovascularisation in cases of retinal pigment epithelial detachments: a review of the Moorfields treatment trial. Br J Ophthalmol (1992) 0.79

Detection of pigment epithelial detachment vascularization in age-related macular degeneration using phase-variance OCT angiography. Clin Ophthalmol (2015) 0.79

Fundus autofluorescence in patients with retinal pigment epithelial (RPE) tears: an in-vivo evaluation of RPE resurfacing. Graefes Arch Clin Exp Ophthalmol (2014) 0.78

Tear of Retinal Pigment Epithelium following YAG Laser Posterior Capsulotomy in a Patient on Anti-VEGF Treatment for AMD: Six Months' Follow-Up. Case Rep Ophthalmol (2012) 0.78

Ultra-high resolution optical coherence tomography of retinal pigment epithelial tear following blunt trauma. Arch Ophthalmol (2006) 0.77

Macular translocation with 360 degrees retinotomy for retinal pigment epithelial tear. Graefes Arch Clin Exp Ophthalmol (2005) 0.77

Spontaneous bilateral giant tears of the retinal pigment epithelium. Br J Ophthalmol (2004) 0.75

Computerised visual field deficits in tears of the retinal pigment epithelium. Br J Ophthalmol (1990) 0.75

Atypical retinal pigment epithelial defects with retained photoreceptor layers: a so far disregarded finding in age related macular degeneration. BMC Ophthalmol (2017) 0.75

Spectral domain optical coherence tomography features of multiple subfoveal retinal pigment epithelial tears after intravitreal bevacizumab. Indian J Ophthalmol (2010) 0.75

Complete resolution of a giant pigment epithelial detachment secondary to exudative age-related macular degeneration after a single intravitreal ranibizumab (lucentis) injection: results documented by optical coherence tomography. Case Rep Ophthalmol (2010) 0.75

Retinal pigment epithelial tear after intravitreal bevacizumab injection for exudative age-related macular degeneration. Oman J Ophthalmol (2014) 0.75

Choroidal thickness in retinal pigment epithelial tear as measured by spectral domain optical coherence tomography. Retina (2014) 0.75

Cellular debris--a key to the aging macula. Br J Ophthalmol (1989) 0.75

Serous pigment epithelium detachment associated with age-related macular degeneration: a possible treatment approach. Med Hypothesis Discov Innov Ophthalmol (2012) 0.75

Change in vision after retinal pigment epithelium tear following the use of anti-VEGF therapy for age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2015) 0.75

Physical disruption of cell-cell contact induces VEGF expression in RPE cells. Mol Vis (2017) 0.75

Bilateral retinal pigment epithelial rips in hypertensive choroidopathy. Taiwan J Ophthalmol (2015) 0.75

Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2015) 0.75

Ageing and degeneration in the macular region: a clinico-pathological study. Br J Ophthalmol (1976) 5.73

Council Lecture. Drusen and their relationship to senile macular degeneration. Aust J Ophthalmol (1980) 2.08

Geographic atrophy of the retinal pigment epithelium. A manifestation of senile macular degeneration. Arch Ophthalmol (1975) 2.03

Experimental retinal detachment in the owl monkey. 3. Electron microscopy of retina and pigment epithelium. Am J Ophthalmol (1968) 1.96

Serous detachments of the retinal pigment epithelium in patients with senile macular disease. Am J Ophthalmol (1979) 1.40

Follow-up study of detachment of the retinal pigment epithelium. Br J Ophthalmol (1980) 1.30

Laser irradiation of retinal tissue. Br Med Bull (1970) 1.15

Disappearance of retino-epithelial scar tissue from ruby laser photocoagulations. Exp Eye Res (1971) 1.06

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol (1995) 10.05

Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol (1995) 3.62

A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet (1999) 3.32

X-linked retinitis pigmentosa. Br J Ophthalmol (1975) 3.11

A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11). Mol Cell (2001) 3.07

A new locus for autosomal dominant retinitis pigmentosa on chromosome 7p. Nat Genet (1993) 2.97

Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa. Nat Genet (2000) 2.82

Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol (2006) 2.67

Close genetic linkage between X-linked retinitis pigmentosa and a restriction fragment length polymorphism identified by recombinant DNA probe L1.28. Nature (1984) 2.52

Mutations in the pre-mRNA splicing factor gene PRPC8 in autosomal dominant retinitis pigmentosa (RP13). Hum Mol Genet (2001) 2.48

RPGR mutation associated with retinitis pigmentosa, impaired hearing, and sinorespiratory infections. J Med Genet (2003) 2.45

Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci (1997) 2.31

The development of neovascularization of senile disciform macular degeneration. Am J Ophthalmol (1973) 2.17

Recent advances in the treatment of senile disciform macular degeneration by photocoagulation. Br J Ophthalmol (1974) 2.14

In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol (1997) 2.10

Senile disciform macular degeneration in the second eye. Br J Ophthalmol (1977) 2.07

Bilateral acute retinal necrosis. Br J Ophthalmol (1978) 2.07

Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol (2001) 2.04

Aging changes in Bruch's membrane. A histochemical and morphologic study. Ophthalmology (1990) 1.99

Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol (1988) 1.90

A 3-bp deletion in the rhodopsin gene in a family with autosomal dominant retinitis pigmentosa. Am J Hum Genet (1991) 1.88

A clinical, psychophysical, and electroretinographic survey of patients with autosomal dominant retinitis pigmentosa. Br J Ophthalmol (1985) 1.87

Mutations in the retinal guanylate cyclase (RETGC-1) gene in dominant cone-rod dystrophy. Hum Mol Genet (1998) 1.84

A mutation in guanylate cyclase activator 1A (GUCA1A) in an autosomal dominant cone dystrophy pedigree mapping to a new locus on chromosome 6p21.1. Hum Mol Genet (1998) 1.81

A completed screen for mutations of the rhodopsin gene in a panel of patients with autosomal dominant retinitis pigmentosa. Hum Mol Genet (1992) 1.80

A mutation in NRL is associated with autosomal dominant retinitis pigmentosa. Nat Genet (1999) 1.79

A clinical study of the vascularity of senile disciform macular degeneration. Am J Ophthalmol (1973) 1.77

Degenerative changes in a retina affected with autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci (1989) 1.75

Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol (1985) 1.74

Functional characterisation and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Br J Ophthalmol (2006) 1.74

Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol (2002) 1.74

Identification of a sixth locus for autosomal dominant retinitis pigmentosa on chromosome 19. Hum Mol Genet (1994) 1.71

Acute zonal occult outer retinopathy: towards a set of diagnostic criteria. Br J Ophthalmol (2005) 1.70

Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci (1992) 1.69

Choroidal perfusion abnormality with age-related Bruch's membrane change. Am J Ophthalmol (1990) 1.66

Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain (1987) 1.66

Drusen as risk factors in age-related macular disease. Am J Ophthalmol (1990) 1.66

Autosomal dominant exudative vitreoretinopathy. Br J Ophthalmol (1980) 1.65

Retinal macroaneurysms. Br J Ophthalmol (1975) 1.64

Retinopathy in haemoglobin C trait. Eye (Lond) (1996) 1.63

The role of axoplasmic transport in the pathogenesis of retinal cotton-wool spots. Br J Ophthalmol (1977) 1.62

Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metab (1997) 1.58

Vitamin A treatment for night blindness in primary biliary cirrhosis. Br Med J (Clin Res Ed) (1984) 1.57

Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol (1994) 1.55

Senile disciform macular degeneration: features indicating suitability for photocoagulation. Br J Ophthalmol (1979) 1.54

Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain (1987) 1.54

Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change. Br J Ophthalmol (1993) 1.51

On the retinal vasculature of the human fovea. Exp Eye Res (1974) 1.50

Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology (1994) 1.49

Low vision services for vision rehabilitation in the United Kingdom. Br J Ophthalmol (2002) 1.47

Autosomal dominant retinitis pigmentosa: four new mutations in rhodopsin, one of them in the retinal attachment site. Genomics (1991) 1.46

Long-term management of abetalipoproteinaemia. Possible role for vitamin E. Arch Dis Child (1977) 1.44

Histopathology of ruby and argon laser lesions in monkey and human retina. A comparative study. Br J Ophthalmol (1975) 1.42

Histopathology of incipient fundus flavimaculatus. Ophthalmology (1991) 1.42

Radiotherapy for age-related macular degeneration. Clin Oncol (R Coll Radiol) (1998) 1.41

Autosomal dominant retinitis pigmentosa with apparent incomplete penetrance: a clinical, electrophysiological, psychophysical, and molecular genetic study. Br J Ophthalmol (1993) 1.41

A comparative histopathological study of argon and krypton laser irradiations of the human retina. Br J Ophthalmol (1979) 1.41

Functional correlates of fundus autofluorescence abnormalities in patients with RPGR or RIMS1 mutations causing cone or cone rod dystrophy. Br J Ophthalmol (2007) 1.40

The role of molecular genetics in the prenatal diagnosis of retinal dystrophies. Eye (Lond) (1995) 1.39

A linkage survey of 20 dominant retinitis pigmentosa families: frequencies of the nine known loci and evidence for further heterogeneity. J Med Genet (1998) 1.39

Sorsby's fundus dystrophy. A light and electron microscopic study. Ophthalmology (1989) 1.38

Experimental retinal branch vein occlusion in rhesus monkeys. I. Clinical appearances. Br J Ophthalmol (1979) 1.37

Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol (1998) 1.35

Visual prognosis of disciform degeneration in myopia. Ophthalmology (1983) 1.34

Distribution of pigment epithelium autofluorescence in retinal disease state recorded in vivo and its change over time. Graefes Arch Clin Exp Ophthalmol (1999) 1.34

Confocal imaging of the fundus using a scanning laser ophthalmoscope. Br J Ophthalmol (1992) 1.32

A fluorescein and indocyanine green angiographic study of choriocapillaris in age-related macular disease. Arch Ophthalmol (1999) 1.31

Sorsby's fundus dystrophy. A clinical study. Ophthalmology (1989) 1.30

Quantitative evaluation of fundus autofluorescence imaged "in vivo" in eyes with retinal disease. Br J Ophthalmol (2000) 1.29

Correlation between lipids extracted from Bruch's membrane and age. Ophthalmology (1993) 1.29

Acute zonal occult outer retinopathy (AZOOR) associated with multifocal choroidopathy. Eye (Lond) (1994) 1.29

Mutations in the RP2 gene cause disease in 10% of families with familial X-linked retinitis pigmentosa assessed in this study. Am J Hum Genet (1999) 1.28

Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments. Br J Ophthalmol (2000) 1.27

Ocular abnormalities in Alagille syndrome. Ophthalmology (1999) 1.25

X-linked recessive fundus dystrophies and their carrier states. Trans Ophthalmol Soc U K (1970) 1.25

Sickle cell retinopathy in Jamaican children: further observations from a cohort study. Br J Ophthalmol (1988) 1.25

Clinical characterisation of a family with retinal dystrophy caused by mutation in the Mertk gene. Br J Ophthalmol (2006) 1.24

Sickle cell retinopathy in young children in Jamaica. Br J Ophthalmol (1982) 1.24

Morphology of posterior segment lesions of the eye in patients with onchocerciasis. Br J Ophthalmol (1976) 1.24

Autosomal dominant cone-rod dystrophy with mutations in the guanylate cyclase 2D gene encoding retinal guanylate cyclase-1. Arch Ophthalmol (2001) 1.24

Retinitis pigmentosa and retinal oedema. Br J Ophthalmol (1978) 1.23

Autosomal dominant cone and cone-rod dystrophy with mutations in the guanylate cyclase activator 1A gene-encoding guanylate cyclase activating protein-1. Arch Ophthalmol (2001) 1.22

Ocular fundus lesions in divers. Lancet (1988) 1.21

Geographical choroidopathy. Br J Ophthalmol (1974) 1.20

Abnormal dark adaptation kinetics in autosomal dominant sector retinitis pigmentosa due to rod opsin mutation. Br J Ophthalmol (1992) 1.20

Linkage to D3S47 (C17) in one large autosomal dominant retinitis pigmentosa family and exclusion in another: confirmation of genetic heterogeneity. Am J Hum Genet (1990) 1.20

Autosomal dominant cone-rod retinal dystrophy (CORD6) from heterozygous mutation of GUCY2D, which encodes retinal guanylate cyclase. Ophthalmology (2000) 1.20

Electrophysiologic studies in birdshot chorioretinopathy. Am J Ophthalmol (1988) 1.20

Assessment of the phenotypic range seen in Doyne honeycomb retinal dystrophy. Arch Ophthalmol (1997) 1.19

Abnormal dark adaptation and rhodopsin kinetics in Sorsby's fundus dystrophy. Invest Ophthalmol Vis Sci (1992) 1.19

Retinal vascular changes in congenital hypertrophy of the retinal pigment epithelium. Br J Ophthalmol (1976) 1.18

Outcome of cataract surgery in patients with retinitis pigmentosa. Br J Ophthalmol (2001) 1.17

Correlation between biochemical composition and fluorescein binding of deposits in Bruch's membrane. Ophthalmology (1992) 1.17

Unruptured aneurysm of the supraclinoid carotid artery. A treatable cause of blindness. Neurology (1970) 1.16

Evolution of age-related macular degeneration with choroidal perfusion abnormality. Am J Ophthalmol (1992) 1.15

Recurrent choroidal neovascularization after laser photocoagulation in Sorsby's fundus dystrophy. Retina (1994) 1.15

The dark choroid in posterior retinal dystrophies. Br J Ophthalmol (1981) 1.15